Genetic Mutations and Demographic, Clinical, and Morphological Aspects of Myofibrillar Myopathy in a French Cohort

被引:14
|
作者
de Siqueira Carvalho, Alzira Alves [1 ,2 ]
Lacene, Emmanuele [2 ]
Brochier, Guy [2 ]
Labasse, Clemance [2 ]
Madelaine, Angeline [2 ]
da Silva, Vinicius Gomes [3 ]
Corazzini, Roseli [3 ]
Papadopoulos, Konstantinos [4 ]
Behin, Anthony [4 ]
Laforet, Pascal [4 ]
Stojkovic, Tania [4 ]
Eymard, Bruno [4 ]
Fardeau, Michel [2 ]
Romero, Norma [2 ]
机构
[1] Fac Med ABC, Dept Neurociencias, Lab Doencas Neuromusculares, Ave Principe Gales 821, BR-09060650 Santo Andre, Brazil
[2] Grp Hosp Pitie Salpetriere, Lab Pathol Musculaire Risler, Paris, France
[3] Fac Med ABC, Dept Neurociencias, Lab Doencas Neuromusculares, Santo Andre, Brazil
[4] Grp Hosp Pitie Salpetriere, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, Paris, France
关键词
myofibrillar myopathy; genetic association analysis; protein aggregation; molecular diagnosis; PROTEIN AGGREGATE MYOPATHIES; ELECTRON-MICROSCOPY; DESMIN POSITIVITY; BODY MYOPATHY; ACCUMULATION; DISEASE; BODIES; MUSCLE;
D O I
10.1089/gtmb.2018.0004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Protein aggregate myopathies (PAM) represent a group of familial or sporadic neuromuscular conditions with marked clinical and genetic heterogeneity that occur in children and adults. Familial PAM includes myofibrillar myopathies defined by the presence of desmin-positive protein aggregates and degenerative intermyofibrillar network changes. PAM is often caused by dysfunctional genes, such as DES, PLEC 1, CRYAB, FLNC, MYOT, ZASP, BAG3, FHL1, and DNAJB6. Objective: To retrospectively analyze genetic mutations and demographic, clinical, and morphological aspects of PAM in a French population. Methods: Forty-eight PAM patients (29 men, 19 women) were divided into two groups, those with genetically (GIM) and nongenetically identified (NGIM) mutations associated with myofibrillar myopathy. Results: Age of myopathy onset ranged from 13 to 68 years. GIM group mutations (81.25%) included DES (14), ZASP (8), FLNC (4), MYOT (4), BAG3 (1), CRYAB (2), and DNAJB6 (6). The MYOT subgroup displayed a significantly older onset age (p=0.029). Autosomal dominant inheritance was found in 74.3% of GIM and 44.4% of NGIM subjects. Overall, 22.9% had Maghrebian heritage, 72.9% Caucasian, and 4.2% Asian. The most common clinical sign was distal muscle weakness (66%) followed by simultaneous distal and proximal weakness in 49%. Eleven patients had contractures, one had a rigid spine, and five had respiratory dysfunction. GIM subjects had greater cardiac involvement (51.7%) versus the NGIM group (33.3%). The average serum creatine kinase level was 393U/L in GIM and 382U/L in NGIM subjects. Morphological analysis showed significant differences among GIM subgroups, including the number of vacuoles and regenerated fibers (ZASP), group atrophy (ZASP), and rubbed out fibers (MYOT). Ultrastructural findings showed significant differences in intranuclear rods, Z-disc thickness, and intranuclear inclusions between gene mutation subgroups. Paracrystalline inclusions were present in three patients (DNAJB6). The most frequent mutation in was in DES, followed by ZASP.Conclusions: GIM and NGIM PAM subjects showed similar results, suggesting that any unknown genes, which cause this disease have characteristics similar to those already described. Considering the complexity of clinical, morphological, and genetic data related to PAM, particularly myofibrillar myopathies, physicians should be careful when diagnosing patients with sporadic PAM.
引用
收藏
页码:374 / 383
页数:10
相关论文
共 50 条
  • [1] Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients
    Selcen, D
    Ohno, K
    Engel, AG
    BRAIN, 2004, 127 : 439 - 451
  • [2] Clinical, morphological and genetic characterization of a series of 27 Spanish patients with myofibrillar myopathy
    Olive, Montse
    Shatunov, Alexey
    Goldfarb, Lev
    Pou, Adolf
    Armstrong, Judith
    Moreno, Dolores
    Pradas, Jesus
    Huerta, Mariano
    Fischer, Dirk
    Povedano, Monica
    Jauma, Serge
    Ferrer, Isidro
    NEUROMUSCULAR DISORDERS, 2006, 16 : S108 - S108
  • [3] Myofibrillar Myopathy 5: Clinical, Morphological and Genetic Studies of a Cohort of Chinese Patients with Novel Pathogenic FLNC Nonsense Mutation
    Gao, Yuan
    Chang, Shek-kwan Richard
    Ho, Siu-lun Ronnie
    Law, Chun-yiu
    Mak, Windsor
    Tse, Man-yu Mona
    Lam, Ching-wan
    Ho, Shu-leong
    NEUROLOGY, 2020, 94 (15)
  • [4] CLINICAL AND MOLECULAR SPECTRUM OF MYOFIBRILLAR MYOPATHY IN A BRAZILIAN COHORT
    Silva, A. M. S.
    Mendonca, R. H.
    Camelo, C. G.
    Estephan, E. P.
    Moreno, C. A. M.
    Carvalho, M. S.
    Nascimento, A. M.
    Kulikowski, L. D.
    Dias, A. T.
    Oliveira, A. S. B.
    Reed, U. C.
    Zanoteli, E.
    MUSCLE & NERVE, 2019, 60 : S17 - S17
  • [5] Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort
    Catteruccia, Michela
    Fattori, Fabiana
    Codemo, Valentina
    Ruggiero, Lucia
    Maggi, Lorenzo
    Tasca, Giorgio
    Fiorillo, Chiara
    Pane, Marika
    Berardinelli, Angela
    Verardo, Margherita
    Bragato, Cinzia
    Mora, Marina
    Morandi, Lucia
    Bruno, Claudio
    Santoro, Lucio
    Pegoraro, Elena
    Mercuri, Eugenio
    Bertini, Enrico
    D'Amico, Adele
    NEUROMUSCULAR DISORDERS, 2013, 23 (03) : 229 - 238
  • [6] Clinical and genetic analysis of 40 patients with myofibrillar myopathy (MFM)
    Selcen, D
    Ohno, K
    Engel, AG
    NEUROLOGY, 2002, 58 (07) : A389 - A390
  • [7] Clinical, pathological and genetic findings in two patients with myofibrillar myopathy
    Sheerin, U. M.
    Omer, S.
    Al-Sarraj, S.
    Bushby, K.
    Al-Memar, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (03): : 360 - 360
  • [8] The clinical, myopathological characteristics of a Chinese cohort of myofibrillar myopathy: a retrospective study
    Luo, Y.
    Li, Q.
    Duan, H.
    Bi, F.
    Yang, H.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S107 - S107
  • [9] Clinical, morphologic and genetic analysis of 53 patients with myofibrillar myopathy (MFM)
    Selcen, DS
    Ohno, K
    Engel, AG
    NEUROMUSCULAR DISORDERS, 2002, 12 (7-8) : 757 - 758
  • [10] BETHLEM MYOPATHY - CLINICAL AND GENETIC-ASPECTS
    JOBSIS, GJ
    BARTH, PG
    BOERS, JM
    BAAS, F
    BOLHUIS, PA
    DEVISSER, M
    NEUROLOGY, 1995, 45 (04) : A407 - A407